Table 1.
Infant demographics by surfactant typea.
| Beractant N = 2890 (%) |
Calfactant N = 1936 (%) |
Poractant alfa N = 2976 (%) |
Total N = 7802 (%) |
|
|---|---|---|---|---|
| GA (weeks) | ||||
| ≤25 | 529 (18) | 740 (38) | 941 (32) | 2210 (28) |
| 26–28 | 748 (26) | 601 (31) | 755 (25) | 2104 (27) |
| 29–32 | 778 (27) | 410 (21) | 694 (23) | 1882 (24) |
| 33–36 | 835 (29) | 185 (10) | 586 (20) | 1606 (21) |
| BW (grams) | n = 2889 | n = 1935 | n = 2975 | n = 7799 |
| <1000 | 1039 (36) | 1162 (60) | 1478 (50) | 3679 (47) |
| 1000–499 | 696 (24) | 424 (22) | 647 (22) | 1767 (23) |
| 1500–2499 | 769 (27) | 270 (14) | 576 (19) | 1615 (21) |
| >2499 | 385 (13) | 79 (4) | 274 (9) | 738 (9) |
| Postnatal age (days) | ||||
| 3–<7 | 1540 (53) | 537 (28) | 1436 (48) | 3513 (45) |
| 7–13 | 448 (16) | 510 (26) | 524 (18) | 1482 (19) |
| 14–20 | 228 (8) | 237 (12) | 287 (10) | 752 (10) |
| >20 | 674 (23) | 652 (34) | 729 (25) | 2055 (26) |
| Race/ethnicity | n = 2789 | n = 1868 | n = 2858 | n = 7515 |
| White | 1428 (51) | 1007 (54) | 1499 (52) | 3934 (52) |
| African American | 595 (21) | 463 (25) | 627 (22) | 1685 (22) |
| Hispanic | 678 (24) | 326 (17) | 598 (21) | 1602 (21) |
| Other | 88 (3) | 72 (4) | 134 (5) | 294 (4) |
| Prenatal steroids | 1699 (59) | 1433 (74) | 2129 (72) | 5261 (67) |
| PDA ligation | 275 (10) | 401 (21) | 366 (12) | 1042 (13) |
| Male | 1741 (60) | 1113/1935 (58) | 1782/2974 (60) | 4636/7799 (59) |
| Received ≥1 prior dose of surfactantb | 821/1583 (52) | 579/1019 (57) | 1205/1731 (70) | 2605/4333 (60) |
| On-label for BW and GA | 1268 (44) | 1303 (67) | 1661 (56) | 4232 (54) |
BW Birth weight, GA gestational age, PDA patent ductus arteriosus.
aInfants who were transferred in and had no documentation of prior surfactant were excluded from this analysis.
bIncludes infants with and without prior receipt of surfactant within the labeled PNA.